-

07:30:58 PM

Latest AEMD Stock Market News

AEMD - Aethlon Medical Inc

12/16/20 8:02 AM

Nasdaq : AEMD

clinical trial

Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, announced today that the first patient has been treated in the Company's first-in-human Early

RHEA-AI

very positive

11/03/20 8:01 AM

Nasdaq : AEMD

management

Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, announced today the appointment of Charles J. Fisher, Jr., M.D., as Chief Executive Officer, effective

RHEA-AI

very positive

10/28/20 4:15 PM

Nasdaq : AEMD

earnings

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for its second quarter ended September 30, 2020 and provided

RHEA-AI

neutral

10/19/20 8:01 AM

Nasdaq : AEMD

earnings

Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its second quarter fiscal year 2021, ended September 30, 2020, at 4:15 pm Eastern time

RHEA-AI

neutral

09/09/20 8:01 AM

Nasdaq : AEMD

conferences

Aethlon Medical to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced that Timothy C. Rodell, M.D., Chief Executive Officer, is scheduled to provide

RHEA-AI

neutral

08/27/20 8:01 AM

Nasdaq : AEMD

conferences

Aethlon Medical to Present at the LD Micro 500 Virtual Conference

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced that CEO, Timothy C. Rodell, MD, is scheduled to present to a live audience at

RHEA-AI

neutral

08/11/20 4:15 PM

Nasdaq : AEMD

earnings

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for its first quarter ended June 30, 2020 and provided an

RHEA-AI

neutral

08/06/20 8:00 AM

Nasdaq : AEMD

Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH Grant for Head and Neck Cancer

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in oncology and viral diseases announced today that the National Institute for Dental and Craniofacial Research (NIDCR), a unit of the National

RHEA-AI

positive

08/04/20 12:18 PM

Nasdaq : AEMD

earnings

Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 11, 2020

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its first quarter fiscal year 2021, ended June 30, 2020, at 4:15 pm Eastern time on

RHEA-AI

neutral

06/25/20 4:15 PM

Nasdaq : AEMD

earnings

Aethlon Medical Announces Fiscal Year Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to d...

RHEA-AI

neutral

Prev 1 2 3 Next

AEMD Data

industryAnalytical Laboratory Instrument Manufacturing
websitewww.aethlonmedical.com
ceoTimothy Rodell
security nameAethlon Medical Inc
issue typecs
sectorManufacturing
sic code3826
employees8
tagsHealth Technology,Medical Specialties,Manufacturing,Analytical Laboratory Instrument Manufacturing
address9635 Granite Ridge Dr Ste 100
address2
stateCalifornia
citySan Diego
zip92123
countryUS
phone18584597800

AEMD Description:

Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression.